![](/img/cover-not-exists.png)
Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up
Hussein A. Sheashaa, Mohamed A. Bakr, Mohamed Ashraf Fouda, Khalid F. El-dahshan, Amany M. Ismail, Mohamed A. Sobh, Mohamed A. GhoneimVolume:
39
Language:
english
Pages:
3
DOI:
10.1007/s11255-006-9091-8
Date:
March, 2007
File:
PDF, 111 KB
english, 2007